2026-07-21T14:14:51Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/154902025-06-24T16:03:37Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608col_20.500.12105_19609

00925njm 22002777a 4500 dc Kissling, E author Valenciano, M author I-MOVE Case-Control Studies Team author Jimenez-Jorge, Silvia author Mateo-Ontañon, Salvador de author Pozo Sanchez, Francisco author Ledesma, Juan author Casas Flecha, Inmaculada author Larrauri, Amparo author 2011-03-17 We present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness(ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We included patients meeting the European Union ILI case definition and swabbed less than eight days after symptom onset. Laboratory-confirmed influenza cases were compared with negative controls. The adjusted vaccine effectiveness was 42.3% (95% CI: -7.3 to 69.0%), suggesting moderate protection of the seasonal vaccine. Euro Surveill. 2011 Mar 17;16(11):19818. 10.2807/ese.16.11.19818-en 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 21435329 http://hdl.handle.net/20.500.12105/15490 Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study